Personal Products & Services
Compare Stocks
2 / 10Stock Comparison
MRM vs PLNT
Revenue, margins, valuation, and 5-year total return — side by side.
Leisure
MRM vs PLNT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Personal Products & Services | Leisure |
| Market Cap | $6M | $3.52B |
| Revenue (TTM) | $11.91B | $1.38B |
| Net Income (TTM) | $615M | $229M |
| Gross Margin | 26.4% | 54.2% |
| Operating Margin | -0.9% | 29.6% |
| Forward P/E | 6.4x | 13.0x |
| Total Debt | $3.96B | $443M |
| Cash & Equiv. | $329M | $346M |
MRM vs PLNT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 20 | May 26 | Return |
|---|---|---|---|
| MEDIROM Healthcare … (MRM) | 100 | 8.1 | -91.9% |
| Planet Fitness, Inc. (PLNT) | 100 | 56.7 | -43.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MRM vs PLNT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MRM carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.
- Rev growth 21.5%, EPS growth 28.1%, 3Y rev CAGR 15.3%
- PEG 0.13 vs PLNT's 1.80
- 21.5% revenue growth vs PLNT's 12.1%
PLNT is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 203.6% 10Y total return vs MRM's -92.3%
- Lower volatility, beta 0.31, current ratio 2.11x
- Beta 0.31, yield 0.0%, current ratio 2.11x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 21.5% revenue growth vs PLNT's 12.1% | |
| Value | Lower P/E (6.4x vs 13.0x), PEG 0.13 vs 1.80 | |
| Quality / Margins | 16.5% margin vs MRM's 5.2% | |
| Dividends | 0.0% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +47.9% vs PLNT's -56.7% | |
| Efficiency (ROA) | 11.8% ROA vs PLNT's 7.4%, ROIC -0.3% vs 35.2% |
MRM vs PLNT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MRM vs PLNT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
PLNT leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MRM is the larger business by revenue, generating $11.9B annually — 8.6x PLNT's $1.4B. PLNT is the more profitable business, keeping 16.5% of every revenue dollar as net income compared to MRM's 5.2%. On growth, PLNT holds the edge at +21.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $11.9B | $1.4B |
| EBITDAEarnings before interest/tax | $338M | $568M |
| Net IncomeAfter-tax profit | $615M | $229M |
| Free Cash FlowCash after capex | -$2.0B | $267M |
| Gross MarginGross profit ÷ Revenue | +26.4% | +54.2% |
| Operating MarginEBIT ÷ Revenue | -0.9% | +29.6% |
| Net MarginNet income ÷ Revenue | +5.2% | +16.5% |
| FCF MarginFCF ÷ Revenue | -16.8% | +19.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -99.4% | +21.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +99.5% | +30.0% |
Valuation Metrics
MRM leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
At 6.4x trailing earnings, MRM trades at a 62% valuation discount to PLNT's 16.8x P/E. Adjusting for growth (PEG ratio), MRM offers better value at 0.13x vs PLNT's 1.80x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $6M | $3.5B |
| Enterprise ValueMkt cap + debt − cash | $29M | $3.6B |
| Trailing P/EPrice ÷ TTM EPS | 6.36x | 16.80x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 13.04x |
| PEG RatioP/E ÷ EPS growth rate | 0.13x | 1.80x |
| EV / EBITDAEnterprise value multiple | 16.75x | 6.57x |
| Price / SalesMarket cap ÷ Revenue | 0.11x | 2.66x |
| Price / BookPrice ÷ Book value/share | 0.89x | — |
| Price / FCFMarket cap ÷ FCF | — | 13.82x |
Profitability & Efficiency
PLNT leads this category, winning 6 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), PLNT scores 9/9 vs MRM's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +2.4% | — |
| ROA (TTM)Return on assets | +11.8% | +7.4% |
| ROICReturn on invested capital | -0.3% | +35.2% |
| ROCEReturn on capital employed | -0.5% | +14.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 9 |
| Debt / EquityFinancial leverage | 3.33x | — |
| Net DebtTotal debt minus cash | $3.6B | $97M |
| Cash & Equiv.Liquid assets | $329M | $346M |
| Total DebtShort + long-term debt | $4.0B | $443M |
| Interest CoverageEBIT ÷ Interest expense | 0.56x | 6.73x |
Total Returns (Dividends Reinvested)
PLNT leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PLNT five years ago would be worth $5,705 today (with dividends reinvested), compared to $1,176 for MRM. Over the past 12 months, MRM leads with a +47.9% total return vs PLNT's -56.7%. The 3-year compound annual growth rate (CAGR) favors PLNT at -15.1% vs MRM's -41.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -40.8% | -59.9% |
| 1-Year ReturnPast 12 months | +47.9% | -56.7% |
| 3-Year ReturnCumulative with dividends | -80.0% | -38.9% |
| 5-Year ReturnCumulative with dividends | -88.2% | -42.9% |
| 10-Year ReturnCumulative with dividends | -92.3% | +203.6% |
| CAGR (3Y)Annualised 3-year return | -41.5% | -15.1% |
Risk & Volatility
Evenly matched — MRM and PLNT each lead in 1 of 2 comparable metrics.
Risk & Volatility
MRM is the less volatile stock with a -0.54 beta — it tends to amplify market swings less than PLNT's 0.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PLNT currently trades 38.4% from its 52-week high vs MRM's 26.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.54x | 0.31x |
| 52-Week HighHighest price in past year | $4.45 | $114.47 |
| 52-Week LowLowest price in past year | $0.72 | $37.03 |
| % of 52W HighCurrent price vs 52-week peak | +26.1% | +38.4% |
| RSI (14)Momentum oscillator 0–100 | 49.2 | 32.8 |
| Avg Volume (50D)Average daily shares traded | 378K | 1.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $119.17 |
| # AnalystsCovering analysts | — | 26 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | $0.02 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +14.2% |
PLNT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MRM leads in 1 (Valuation Metrics). 1 tied.
MRM vs PLNT: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is MRM or PLNT a better buy right now?
For growth investors, MEDIROM Healthcare Technologies Inc.
(MRM) is the stronger pick with 21. 5% revenue growth year-over-year, versus 12. 1% for Planet Fitness, Inc. (PLNT). MEDIROM Healthcare Technologies Inc. (MRM) offers the better valuation at 6. 4x trailing P/E, making it the more compelling value choice. Analysts rate Planet Fitness, Inc. (PLNT) a "Buy" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MRM or PLNT?
On trailing P/E, MEDIROM Healthcare Technologies Inc.
(MRM) is the cheapest at 6. 4x versus Planet Fitness, Inc. at 16. 8x.
03Which is the better long-term investment — MRM or PLNT?
Over the past 5 years, Planet Fitness, Inc.
(PLNT) delivered a total return of -42. 9%, compared to -88. 2% for MEDIROM Healthcare Technologies Inc. (MRM). Over 10 years, the gap is even starker: PLNT returned +203. 6% versus MRM's -92. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MRM or PLNT?
By beta (market sensitivity over 5 years), MEDIROM Healthcare Technologies Inc.
(MRM) is the lower-risk stock at -0. 54β versus Planet Fitness, Inc. 's 0. 31β — meaning PLNT is approximately -157% more volatile than MRM relative to the S&P 500.
05Which is growing faster — MRM or PLNT?
By revenue growth (latest reported year), MEDIROM Healthcare Technologies Inc.
(MRM) is pulling ahead at 21. 5% versus 12. 1% for Planet Fitness, Inc. (PLNT). On earnings-per-share growth, the picture is similar: Planet Fitness, Inc. grew EPS 31. 0% year-over-year, compared to 28. 1% for MEDIROM Healthcare Technologies Inc.. Over a 3-year CAGR, MRM leads at 15. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MRM or PLNT?
Planet Fitness, Inc.
(PLNT) is the more profitable company, earning 16. 5% net margin versus 1. 8% for MEDIROM Healthcare Technologies Inc. — meaning it keeps 16. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PLNT leads at 29. 8% versus -0. 2% for MRM. At the gross margin level — before operating expenses — PLNT leads at 82. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — MRM or PLNT?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is MRM or PLNT better for a retirement portfolio?
For long-horizon retirement investors, MEDIROM Healthcare Technologies Inc.
(MRM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 54)). Both have compounded well over 10 years (MRM: -92. 3%, PLNT: +203. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between MRM and PLNT?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MRM is a small-cap high-growth stock; PLNT is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.